STAT

JULY 18, 2023

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies. Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates.

98

98

Pharmaceutical Technology

NOVEMBER 2, 2022

Pfizer has reported a 6% decline in revenue to $22.6bn in the third quarter (Q3) of 2022 as against $24bn in the same quarter last year. In addition, we continue to make progress toward our goal of adding at least $25 billion in risk-adjusted 2030 revenues to Pfizer’s portfolio through business development.”.

116

116

pharmaphorum

JANUARY 17, 2022

The Consumer Healthcare business is a Joint Venture between GSK and Pfizer, with GSK holding a majority controlling interest of 68% and Pfizer 32%. GSK explained its decision to reject the proposals, “on the basis that they fundamentally undervalued the Consumer Healthcare business and its future prospects”.

119

119

Pharmaceutical Technology

OCTOBER 6, 2022

Pfizer has acquired all the outstanding shares of the common stock of biopharmaceutical firm Global Blood Therapeutics (GBT) in a deal worth nearly $5.4bn. With the latest acquisition, GBT became a wholly-owned Pfizer subsidiary. The total enterprise value comprised debt and the net of cash acquired.

FDA 115

FDA 115

pharmaphorum

JUNE 1, 2022

It also confirmed that Pfizer – which holds a 32% stake in the current consumer health joint venture – plans to sell its stake once Haleon becomes independent. There had been some debate over Pfizer’s plans, as it previously said it would sell its shares in the new company, although GSK had suggested it may remain a shareholder. .”

Vaccines 105

Vaccines 105

Pharmaceutical Technology

OCTOBER 4, 2022

Pfizer has acquired commercial-stage biopharmaceutical firm Biohaven Pharmaceutical for $148.50 In May, Pfizer entered a definitive agreement to acquire all outstanding shares of Biohaven which were not previously held by the former. . With the takeover, Biohaven became a wholly-owned Pfizer subsidiary.

FDA 106

FDA 106

Pharmaceutical Technology

FEBRUARY 1, 2023

Pfizer has reported a 30% operational growth in revenues to $100.3bn in full-year 2022 compared with $81.2bn reported last year. The post Pfizer reports 30% operational growth in full-year 2022 revenues appeared first on Pharmaceutical Technology. The revenues grew 2% operationally excluding Paxlovid and Comirnaty’s contributions.

104

104

pharmaphorum

DECEMBER 2, 2020

Few companies embody the term ‘pharma giant’ as much as Pfizer. Pfizer was founded in 1849 by two recent German immigrants to the USA, Charles Pfizer and Charles Erhart. Pfizer’s Tokyo building. Under his stewardship, Pfizer’s expertise in scientific production methods developed greatly.

Compounding 128

Compounding Vaccines Pharmaceutical Companies Pharmaceutical Companies 128

STAT

OCTOBER 27, 2022

Rise and shine, another busy day is on the way. Have a great day, everyone … Pfizer is the target of an Italian probe alleging the company hid at least $1.2 Italy’s finance police have alleged that Pfizer Italia transferred excess capital to affiliates in the U.S. Autumn, after all, is in full swing.

Packaging 90

Packaging FDA Vaccines 90

Pharmaceutical Technology

JULY 29, 2022

Pfizer has reported a 53% operational growth in revenues to $27.7bn in the second quarter (Q2) of 2022 compared to $18.9bn in the same quarter last year. In May, Pfizer reported an 82% operational growth in revenues to $25.7bn in Q1 2022 from $14.5bn in Q1 2021. A 92% growth in adjusted diluted EPS to $2.04 in the prior-year quarter.

105

105

Pharmaceutical Technology

MARCH 10, 2023

The US Food and Drug Administration (FDA) has granted approval for Pfizer ’s Zavzpret (zavegepant) for the acute treatment of migraine in adult patients with or without aura. Zavzpret underscores Pfizer’s commitment to delivering an additional treatment option to help people with migraine gain relief and get back to their daily lives.

FDA 98

FDA 98

pharmaphorum

JULY 23, 2021

GlaxoSmithKline has said that Brian McNamara – currently head of its three-year-old consumer health joint venture with Pfizer – will retain the top job at the business after it is hived off into a separate company next year. The appointment, which had been expected, was confirmed in a statement by GSK’s board today.

Vaccines 111

Vaccines 111

STAT

SEPTEMBER 20, 2022

Of course, we are busy foraging for items of interest and have selected a few to help you get started on your own mission at hand. Haleon, spun out of GSK as an independent company in July as the world’s biggest standalone consumer health business, comprises consumer health assets once owned by GSK and Pfizer.

Compounding 90

Compounding FDA 90

Pharmaceutical Technology

JUNE 30, 2022

Pfizer and BioNTech have entered a new vaccine supply agreement worth $3.2bn with the US government to supply further doses of their Covid-19 vaccine. On receiving the initial 105 million vaccine doses, the US government will make the agreed payment to Pfizer and BioNTech.

Vaccines 98

Vaccines FDA 98

pharmaphorum

NOVEMBER 2, 2021

Rocketing sales of COVID-19 vaccine Comirnaty have allowed Pfizer to raise its full-year forecasts for the shot once again to a whopping $36 billion, more than double its predictions just a few months ago. The tally accounted for more than half of Pfizer’s total revenues of $24.1 Pfizer said it now expects to deliver 2.3

Vaccines 98

Vaccines 98

pharmaphorum

AUGUST 8, 2022

Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the $68.50-per-share And Pfizer with its resources should be able to ramp this no problem. It’s worth noting that this isn’t Pfizer’s first deal in SCD.

Vaccines 111

Vaccines FDA 111

STAT

MAY 4, 2023

Rise and shine, another busy day is on the way. A vaccine that was developed by Pfizer and aimed at the same demographic is expected to be approved by the end of the month. We can tell by the volume of email arriving this morning and the cacophony of vehicular sounds outside our window.

Vaccines 93

Vaccines FDA Hospitals 93

STAT

APRIL 9, 2024

Rise and shine, everyone, another busy day is on the way. We can tell because countless birds are chirping outside our window, the pace of motor vehicles passing by is picking up, and the official mascots are busy foraging for snacks on the official grounds. As for us, we are engaged in the usual ritual of brewing cups of stimulation.

Vaccines 74

Vaccines 74

STAT

JULY 18, 2023

Rise and shine, everyone, another busy day is on the way. Pfizer and venture capital firm Flagship Pioneering agreed to invest $100 million to discover and develop 10 new potential drugs targeting diseases with few or no treatment options , STAT  says. Flagship, As for us, we are up to the usual. Three patients died.

Hospitals 92

Hospitals 92

Pharmaceutical Technology

DECEMBER 20, 2022

Biotechnology firm LianBio has announced that Pfizer opted in to secure the right to develop and commercialise the respiratory syncytial virus (RSV) therapeutic candidate, sisunatovir, in Mainland China, Hong Kong, Macau, and Singapore. Pfizer acquired ReViral along with its portfolio of RSV therapeutic candidates in June this year.

Vaccines 64

Vaccines 64

PharmaVoice

FEBRUARY 8, 2023

Vlad Coric’s offbeat business strategy paid off once with a Pfizer buyout. Can he do it again?

52

52

pharmaphorum

JULY 22, 2022

Drugmakers Pfizer and Flynn Pharma have been fined £70 million ($84 million) by the UK Competition and Markets Authority (CMA) for overcharging the NHS for a widely-used epilepsy drug. Pfizer is bearing the brunt of the penalty with a £63 million fine, with Flynn on the hook for £6.7

111

111

pharmaphorum

FEBRUARY 8, 2022

Pfizer reckons it will make a whopping $22 billion in sales of its oral COVID-19 antiviral Paxlovid in 2022, with another $32 billion from its BioNTech-partnered coronavirus vaccine Comirnaty. “Pfizer…has made more than enough money from this crisis. .” “Pfizer…has made more than enough money from this crisis.

Vaccines 98

Vaccines 98

pharmaphorum

JANUARY 6, 2022

Outsourcing services are on of the pillars of Merck’s business, delivered via its process solutions unit, part of the group’s life sciences division. Exelead was part of that success, helping to manufacture vaccine precursors for the Pfizer/BioNTech shot Comirnaty. The unit contributed almost €3.4

Vaccines 98

Vaccines 98

pharmaphorum

JANUARY 31, 2022

That’s why Pfizer is working on finding novel ways to expand vaccine access. At Pfizer and BioNTech, this was accomplished by creating cross-functional teams from multiple departments, so that R&D, medical, commercial, manufacturing, supply chain, and digital innovation experts were all working together at the same time.

Vaccines 97

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 97

STAT

MARCH 2, 2023

A spot of rain is falling on the Pharmalot campus, making for a gloomy start to yet another busy day. Food and Drug Administration advisory panel backed a GSK respiratory syncytial virus vaccine, setting it up for a race with rival Pfizer’s RSV vaccine to become the first approved U.S. Nonetheless, our spirits remain sunny.

Vaccines 85

Vaccines FDA 85

Pharma Marketing Network

JULY 19, 2023

Sponsorships can be a powerful way for businesses to connect with their target audience, build relationships with key stakeholders, and promote their brand in a meaningful way. By aligning sponsorships with their brand values, pharmaceutical companies can create synergy that benefits their business and the community.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Patient Care 98

STAT

SEPTEMBER 19, 2023

As for us, we are as busy as ever hunting and gathering items of interest. Pfizer and BioNTech have until the end of the month to give Moderna key information on what it learned and when about critical details of Moderna’s mRNA vaccine formulation that helped rein in the coronavirus pandemic , Bloomberg Law reports.

Vaccines 83

Vaccines 83

Pharmaceutical Technology

DECEMBER 19, 2022

Business Expansion. Business Expansion is one of our largest categories and looks at the core functions of business operations within the sector. Catalent Datwyler Double Rainbow Biosciences Novartis Pfizer Schneider Electric. GSK Lilly Merck Moderna Novartis Pfizer Sonoma. Investments. Product Launches.

52

52

pharmaphorum

JULY 18, 2022

GSK’s main partner in the consumer health joint venture that became Haleon – Pfizer – holds the remaining 32% in the new company and has said that it will sell its stake now that the separation has completed, likely in the last quarter of 2022. billion last year.

Vaccines 124

Vaccines 124

pharmaphorum

FEBRUARY 11, 2022

Ipsen has started exclusive negotiations that could see its global consumer health business sold to fellow French pharma company Mayoly Spindler later this year. Ipsen’s specialty pharma business grew almost 13% to €2.6 The post Ipsen plans sale of consumer health business for €350m appeared first on. billion last year.

103

103

STAT

MAY 23, 2023

Rise and shine, another busy day is on the way. Meanwhile, an oral drug from Pfizer causes a similar amount of weight loss as Ozempic, according to results from a Phase 2 clinical trial, CNBC says. But this is to be expected. So we will pursue the usual routine and trot down to the Pharmalot cafeteria for a cup of stimulation.

Dosage 90

Dosage Insurance 90

European Pharmaceutical Review

JULY 12, 2022

According to a recent survey of patient groups, Roche, Pfizer, ViiV Healthcare and Gilead Sciences are among the top companies for implementing and reporting progress on environmental, social, governance (ESG) activities.

Communication 92

Communication 92

pharmaphorum

MAY 20, 2022

A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in a new app to support patients with atopic dermatitis, which will start rolling out in Europe and Japan later this year. The post Sidekick and Pfizer prep launch of DTx for atopic dermatitis appeared first on.

Patient Care 69

Patient Care 69

STAT

MAY 17, 2023

And what better way to make the time fly than to keep busy. Food and Drug Administration staffers reported that an experimental RSV vaccine developed by Pfizer to protect infants — by vaccinating pregnant women — was effective in preventing severe lower respiratory tract disease , STAT writes. Have heart, though.

Insurance 79

Insurance Vaccines FDA Packaging 79

ISPE

NOVEMBER 2, 2022

Vice President, Hospital Business Unit Global Supply Chain. Tom Cheslock, Vice President, Hospital Business Unit Global Supply Chain at Pfizer presented on “Integrated Manufacturing Excellence–Leading thru Uncertainty.” Pfizer “cleared runway to allow for large-scale vaccine manufacturing before we had a product!”

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Hospitals 98

pharmaphorum

NOVEMBER 28, 2022

The analysis outlines specific examples taken by business, including those taken by some of the largest pharma companies. As part of Oliver Wyman’s report, the firm asked participants in the study to answer how much of a challenge climate change would pose to their business in the years to come.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98